Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Staudacher, Ingo"" wg kryterium: Autor


Tytuł :
Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K channels
Autorzy :
Staudacher, IngoAff1, Aff2
Illg, ClaudiusAff1, Aff2
Chai, SamAff3, Aff4
Deschenes, IsabelleAff3, Aff4
Seehausen, SebastianAff1, Aff2
Gramlich, DominikAff1, Aff2
Müller, Mara ElenaAff1, Aff2
Wieder, TeresaAff1, Aff2
Rahm, Ann-KathrinAff1, Aff2
Mayer, Christina
Schweizer, Patrick A.Aff1, Aff2, Aff6, Aff7
Katus, Hugo A.Aff1, Aff2, Aff6
Thomas, DierkAff1, Aff2, Aff6
Pokaż więcej
Źródło :
Naunyn-Schmiedeberg's Archives of Pharmacology. 391(10):1119-1131
Czasopismo naukowe
Tytuł :
Multiple mechanisms of hERG liability: K current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine
Autorzy :
Obers, Sabrina
Staudacher, Ingo
Ficker, Eckhard
Dennis, Adrienne
Koschny, Ronald
Erdal, Hande
Bloehs, Ramona
Kisselbach, Jana
Karle, Christoph A.
Schweizer, Patrick A.
Katus, Hugo A.
Thomas, Dierk
Pokaż więcej
Źródło :
Naunyn-Schmiedeberg's Archives of Pharmacology. May 2010 381(5):385-400
Czasopismo naukowe
Tytuł :
Cardiac K 2P 13.1 (THIK-1) two-pore-domain K channels: Pharmacological regulation and remodeling in atrial fibrillation.
Autorzy :
Staudacher I; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Seehausen S; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Illg C; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Lugenbiel P; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Schweizer PA; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; Heidelberg Research Center for Molecular Medicine (HRCMM), Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
Katus HA; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Thomas D; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Progress in biophysics and molecular biology [Prog Biophys Mol Biol] 2019 Jul; Vol. 144, pp. 128-138. Date of Electronic Publication: 2018 Jul 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Arrhythmia Agents/*pharmacology
Atrial Fibrillation/*drug therapy
Atrial Fibrillation/*metabolism
Myocardium/*metabolism
Potassium Channels, Tandem Pore Domain/*metabolism
Animals ; Anti-Arrhythmia Agents/therapeutic use ; Atrial Fibrillation/genetics ; Atrial Fibrillation/physiopathology ; Electrophysiological Phenomena/drug effects ; Gene Expression Regulation/drug effects ; Humans ; Mexiletine/pharmacology ; Potassium Channels, Tandem Pore Domain/antagonists & inhibitors ; Potassium Channels, Tandem Pore Domain/genetics ; Swine
Czasopismo naukowe
Tytuł :
Cloning and characterization of zebrafish K 2P 13.1 (THIK-1) two-pore-domain K channels.
Autorzy :
Staudacher I; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Seehausen S; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Gierten J; Department of Pediatric Cardiology, University Hospital Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany; Centre for Organismal Studies, Heidelberg University, Im Neuenheimer Feld 230, 69120 Heidelberg, Germany; Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, Meyerhofstraße 1, 69117 Heidelberg, Germany; Molecular Medicine Partnership Unit, EMBL and Heidelberg University, Im Neuenheimer Feld 350, 69120 Heidelberg, Germany.
Illg C; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Schweizer PA; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; Heidelberg Research Center for Molecular Medicine (HRCMM), Im Neuenheimer Feld 350, 69120 Heidelberg, Germany.
Katus HA; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Thomas D; Department of Cardiology, Medical University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; HCR (Heidelberg Center for Heart Rhythm Disorders), University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2019 Jan; Vol. 126, pp. 96-104. Date of Electronic Publication: 2018 Nov 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Potassium Channels, Tandem Pore Domain/*genetics
Zebrafish/*genetics
Zebrafish Proteins/*genetics
Animals ; Cloning, Molecular ; Humans ; Hydrogen-Ion Concentration ; Peptides/metabolism ; Potassium Channels, Tandem Pore Domain/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Zebrafish Proteins/chemistry ; Zebrafish Proteins/metabolism
Czasopismo naukowe
Tytuł :
Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".
Autorzy :
Sperzel J; Department of Cardiology, Hospital Kerckhoff Klinik GmbH, Bad Nauheim, Germany.
Staudacher I; Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany.
Goeing O; Department of Cardiology, Sana-Hospital Lichtenberg, Berlin, Germany.
Stockburger M; Medical Department I, Havelland Kliniken GmbH, Nauen, Germany.
Meyer T; Department of Public Health, Universität Bielefeld, Bielefeld, Germany.
Gonçalves ASO; inav - privates Institut für angewandte Versorgungsforschung GmbH, Berlin, Germany, .
Sydow H; inav - privates Institut für angewandte Versorgungsforschung GmbH, Berlin, Germany, .
Schoenfelder T; inav - privates Institut für angewandte Versorgungsforschung GmbH, Berlin, Germany, .
Amelung V; inav - privates Institut für angewandte Versorgungsforschung GmbH, Berlin, Germany, .
Pokaż więcej
Źródło :
Medical devices (Auckland, N.Z.) [Med Devices (Auckl)] 2018 Oct 17; Vol. 11, pp. 377-378. Date of Electronic Publication: 2018 Oct 17 (Print Publication: 2018).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies